MedPath

无锡紫杉药业股份有限公司

Ownership
-
Established
2004-05-31
Employees
-
Market Cap
-
Website
www.taxuspharm.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

15

NMPA:15

Drug Approvals

Docetaxel Injection

Product Name
多西他赛注射液
Approval Number
国药准字H20244803
Approval Date
Sep 3, 2024
NMPA

Ramosetron Hydrochloride for Injection

Product Name
注射用盐酸雷莫司琼
Approval Number
国药准字H20060911
Approval Date
May 26, 2021
NMPA

Sodium Demethylcantharidate Injection

Product Name
去甲斑蝥酸钠注射液
Approval Number
国药准字H20064531
Approval Date
Apr 21, 2021
NMPA

Sodium Demethylcantharidate for Injection

Product Name
注射用去甲斑蝥酸钠
Approval Number
国药准字H20060819
Approval Date
Apr 21, 2021
NMPA

Paclitaxel Injection

Product Name
紫杉醇注射液
Approval Number
国药准字H20067344
Approval Date
Apr 20, 2021
NMPA

Paclitaxel Injection

Product Name
紫杉醇注射液
Approval Number
国药准字H20067345
Approval Date
Apr 20, 2021
NMPA

Paclitaxe

Product Name
紫杉醇
Approval Number
国药准字H20093763
Approval Date
Jun 10, 2019
NMPA

Oxaliplatin

Product Name
奥沙利铂
Approval Number
国药准字H20093541
Approval Date
Mar 28, 2019
NMPA

Allopurinol

Product Name
别嘌醇
Approval Number
国药准字H20066701
Approval Date
Jun 20, 2018
NMPA

Oxaliplatin for Injection

Product Name
注射用奥沙利铂
Approval Number
国药准字H20183197
Approval Date
Jun 19, 2018
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.